Table 1

Trial Intervention(s)

Drug	Dose/potency	Dose frequency	Route of administration	Regimen/treatment period	Use
Pembrolizumab	200 mg	Every 3 weeks	Intravenous infusion	Day 1 of each cycle (3-week cycle)	Experimental regimen
Cisplatin*	35 mg/m²	Every 3 weeks	Intravenous infusion	Day 1 and day 8 of each cycle (3-week cycle) for six cycles
Carboplatin*	AUC 5	Every 3 weeks	Intravenous infusion	Day 1 of each cycle (3-week cycle)
Gemcitabine	1250 mg/m²	Every 3 weeks	Intravenous infusion	Day 1 and day 8 of each cycle (3-week cycle) for six cycles

*either cisplatin or carboplatin
AUC, area under the curve.